// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Identifying demographics and co-morbidities among hospitalised adults infected with acute Respiratory Syncytial Virus (RSV)

Christopher Huntley - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pneumolysin mediates neutrophil:platelet aggregation via a P-selectin- and protease-activated receptor-1 (PAR-1)-dependent mechanism

Charles Feldman - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A microlised adhesion assay to assess the effect of E-cigarette vapour (ECV) on pneumococcal adhesion to nasal epithelial cells

Lisa Miyashita - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An imbalanced airway microbiota correlates with greater peak flow decline in virus-induced asthma exacerbations

Ernie Wong - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

Induced sputum microbiome in smoker and non-smoker COPD subjects and its association with lung function in Indian subjects

Baishakhi Ghosh - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Systematic review: Does antibiotic treatment duration affect the outcomes of asthma and COPD exacerbations?

Marie Stolbrink - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

Sputum Pregnancy Zone Protein (PZP) - a potential biomarker of bronchiectasis severity

Alexandria Smith - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The association between gastro-oesophageal reflux and exacerbations of bronchiectasis: data from the EMBARC registry

Melissa Mcdonnell - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Late Breaking Abstract - The prevalence and burden of Pseudomonas aeruginosa among bronchiectasis patients in Europe- data from the FRIENDS cohort

James D. Chalmers - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Patient satisfaction with a Telephone based intervention service post CPAP setup at a District General Hospital

Sajeev Ranmuthu - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Validation of assisted automated scoring versus manual scoring of polysmnography (PSG) studies

Heather Engleman - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Comparison of Manual and Automatic Scoring of limited channel sleep studies:Noxturnal Software correlates well with manual scoring in severe OSA

Nuno Cachada - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Obstructive Sleep Apnoea (OSA): Men vs Women

Raana Haqqee - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

Quality review of a polygraphy service

James Stockley - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Are patients referred for sleep studies similar in different parts of Europe?>

Tarja Saaresranta - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Insomnia

N/A

Minimum clinically important difference of the Epworth Sleepiness Scale

Suhani Patel - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Validation of ASA scoring algorithm for perioperative risk of complications from OSA

Lily Dimitrov - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

OSA and cancer in Europe: the European Sleep Apnea Database (ESADA) experience

Athanasia Pataka - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Sleep apnoea

N/A

CPAP appears to protect kidney function of patients with OSA

James Wingfield Digby - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A retrospective analysis to determine patient suitability for Endobronchial Lung Volume Reduction

Ahmer Irfan - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Copyright © 2026. QuantiNova All rights reserved